Sanofi Correlations
SNYNF Stock | USD 98.50 3.08 3.23% |
The current 90-days correlation between Sanofi and Novartis AG ADR is 0.02 (i.e., Significant diversification). The correlation of Sanofi is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Sanofi Correlation With Market
Average diversification
The correlation between Sanofi and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Sanofi and DJI in the same portfolio, assuming nothing else is changed.
Sanofi |
The ability to find closely correlated positions to Sanofi could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sanofi when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sanofi - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sanofi to buy it.
Moving against Sanofi Pink Sheet
0.73 | VIV | Telefonica Brasil Earnings Call This Week | PairCorr |
0.68 | ASMVF | ASM Pacific Technology | PairCorr |
0.66 | VICI | VICI Properties Earnings Call This Week | PairCorr |
0.6 | EM | Smart Share Global | PairCorr |
0.57 | AHT-PG | Ashford Hospitality Trust | PairCorr |
0.54 | NVS | Novartis AG ADR | PairCorr |
0.53 | AHT-PH | Ashford Hospitality Trust | PairCorr |
0.53 | GAIN | Gladstone Investment | PairCorr |
0.52 | NVSEF | Novartis AG | PairCorr |
0.46 | LVS | Las Vegas Sands | PairCorr |
0.45 | U | Unity Software | PairCorr |
0.37 | TPH | TRI Pointe Homes | PairCorr |
0.36 | ITW | Illinois Tool Works Earnings Call This Week | PairCorr |
0.34 | LUMN | Lumen Technologies Earnings Call Next Week | PairCorr |
0.33 | PHVS | Pharvaris BV Earnings Call This Week | PairCorr |
0.68 | HXL | Hexcel Earnings Call Tomorrow | PairCorr |
0.63 | TWI | Titan International Earnings Call This Week | PairCorr |
0.61 | KAR | KAR Auction Services | PairCorr |
0.61 | EBYH | Strainsforpains | PairCorr |
0.58 | DLTR | Dollar Tree | PairCorr |
0.57 | AHT-PF | Ashford Hospitality Trust | PairCorr |
0.56 | ACEL | Accel Entertainment Earnings Call This Week | PairCorr |
0.54 | BNS | Bank of Nova Scotia | PairCorr |
0.51 | ZVIA | Zevia Pbc | PairCorr |
0.51 | CBL | CBL Associates Properties | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Sanofi Pink Sheet performing well and Sanofi Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Sanofi's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NVS | 1.02 | (0.01) | (0.08) | 0.19 | 1.22 | 2.36 | 6.56 | |||
AZN | 1.16 | (0.04) | (0.06) | 0.15 | 1.38 | 2.61 | 6.69 | |||
GSK | 1.37 | (0.04) | (0.05) | 0.15 | 1.85 | 2.39 | 8.44 | |||
RHHBY | 1.24 | (0.05) | (0.08) | 0.13 | 1.38 | 2.51 | 6.81 | |||
BMY | 1.42 | (0.20) | (0.09) | 0.02 | 2.06 | 2.63 | 8.99 | |||
SNY | 1.24 | (0.13) | (0.09) | 0.05 | 1.64 | 2.32 | 9.05 | |||
BAYRY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
MRK | 1.40 | (0.08) | (0.04) | 0.13 | 1.82 | 2.90 | 10.58 | |||
ABBV | 1.26 | (0.06) | (0.02) | 0.15 | 1.72 | 2.66 | 8.99 | |||
GILD | 1.55 | (0.10) | (0.03) | 0.12 | 1.85 | 3.07 | 11.41 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Sanofi without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
All Next | Launch Module |
Sanofi Corporate Management
Roy Papatheodorou | Gen VP | Profile | |
Josephine Fubara | Chief Care | Profile | |
Paul Hudson | CEO Director | Profile | |
Pierre Chancel | Sr Marketing | Profile | |
Bruno Mnard | Chief officer | Profile | |
Laurent Gilhodes | Principal Accounting | Profile |